# Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women

> **NCT03753776** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 232 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Placebo pills of Radium bromatum
- **DRUG:** Radium bromatum pills
- **DRUG:** Radium bromatum/Apis mellifica/Belladonna placebo pills
- **DRUG:** Radium bromatum/Apis mellifica/Belladonna pills

## Key facts

- **NCT ID:** NCT03753776
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-15
- **Primary completion:** 2024-01-05
- **Final completion:** 2024-04-05
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03753776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03753776, "Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03753776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*